WATSON LABS INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?
WATSON LABS INC has seventy-five approved drugs.
There are eleven tentative approvals on WATSON LABS INC drugs.
Drugs and US Patents for WATSON LABS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Inc | CELECOXIB | celecoxib | CAPSULE;ORAL | 200562-001 | Feb 11, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 063008-001 | Sep 29, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | TICAGRELOR | ticagrelor | TABLET;ORAL | 208390-001 | Sep 4, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 079167-003 | Apr 29, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs Inc | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 077285-001 | Nov 26, 2008 | AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.